Updated on 19 October 2026
Seeking to join consortium for Innovative Healthcare Interventions for NCDs
Scientific project manager at Empa - Lab for Biomimetic Membranes and Textiles
St. Gallen, Switzerland
About
The Body Monitoring Group, part of Empa’s Laboratory for Biomimetic Membranes and Textiles and led by Dr. Simon Annaheim, investigates mechanical and thermal interactions between the human body and materials. The group combines human-subject trials with physical and virtual models to improve the reliability and robustness of textile-integrated and textile-based sensor systems. It develops advanced algorithms to assess signal quality and applies AI-based models to evaluate health, stress, and comfort-related conditions. The overarching aim is to develop multisensing approaches for continuous physiological monitoring in patients, workers, and athletes. They integrate biomimetic structures, sensing materials, and advanced biological models to advance functional and smart materials from laboratory research to real-world applications, supporting the Swiss industry and society.
Topic
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
Organoids and bionanomaterials customization
Fabrizio Gelain
Principal Investigator - Director of Research Center at Casa Sollievo della Sofferenza
Milan, Italy
Project cooperation
Swiss Applied Research Partner – MedTech, BioTech, AI & Product Development
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
- Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Jimmy Bron
Head of Swiss HealthTech Center at Switzerland Innovation Park Biel/Bienne
Biel/Bienne, Switzerland
Project cooperation
Artificial Intelligence and Digital Innovation for healthcare
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Andrés Arias Navarro
Project Manager at IDENER R&D - AI Division
Sevilla, Spain